Abbott’s Confirm Rx insertable cardiac monitor gets a CE Mark

Due to the increasing cardiac problems, there are a number of companies coming up with various technologies for the best of the patient care. Abbott, a well-known medical technology company has come up with a new cardiac monitoring device, which has been given a CE Mark this year. Hence, the Confirm Rx insertable cardiac monitor’s marking has given it an approval to be sold in almost 10 countries within the European region.

According to Abbott, this is the world’s first smartphone-attuned ICM. The device has been designed in such a way that it can continuously monitor the heart’s rhythm and quickly transfer the necessary information using the myMerlin mobile app. This system helps the physicians care and monitor their patients remotely and also diagnose various arrhythmias, for instance atrial fibrillation.

Along with the launch of the new cardiac monitoring system, the company has developed a new wireless technology that enables the ICM to connect as well as communicate with the app downloaded on a patient’s phone. The use of the app, instead of the traditional bedside transmitters attached to the monitoring device that limits the patient’s mobility, is way too efficient and comfortable for them. The new system is thin, easy, a spontaneous one-touch indication-based programming, and a remotely monitoring device using the Patient Care Network. The app is available in 35 languages and helps patients stay connected to their doctors.

The new connected system lets patients share their symptoms via their smartphones to their physicians securely and if any such transmission is missed then the alert messages are flashed. The use of such connected devices helps build a strong bond between the patients and the physicians and also make remotely monitoring possible that to as per the patient’s comfort.

Abbott has designed the cardiac monitoring device with highest data security and privacy such that both the patients and the doctors are at peace when it comes to transmitting critical data. The new technology-based device is going to prove to be a turning point in the history of the healthcare.

Hence, stay tuned for keeping yourself updated on the latest medical devices.

Navya has joined Medical Device News on the 1 January 2017 as a content writer. She has previously worked as a copyeditor and data scientist. She has recently started her career in the field of content writing due to her interest in reading and writing. She has a Master’s degree in biotechnology. Her hobbies are reading, surfing online and going on adventurous trips. She can be reached at